CAS 40400-13-3|α-Bromo-2-iodotoluene
Introduction：Basic information about CAS 40400-13-3|α-Bromo-2-iodotoluene, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | α-Bromo-2-iodotoluene | ||
|---|---|---|---|
| CAS Number | 40400-13-3 | Molecular Weight | 296.931 |
| Density | 2.1±0.1 g/cm3 | Boiling Point | 278.8±15.0 °C at 760 mmHg |
| Molecular Formula | C7H6BrI | Melting Point | 54-60 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 122.4±20.4 °C |
| Symbol | GHS05, GHS07, GHS08 | Signal Word | Danger |
Names
| Name | 2-Iodobenzyl bromide |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 2.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 278.8±15.0 °C at 760 mmHg |
| Melting Point | 54-60 °C(lit.) |
| Molecular Formula | C7H6BrI |
| Molecular Weight | 296.931 |
| Flash Point | 122.4±20.4 °C |
| Exact Mass | 295.869751 |
| LogP | 3.95 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.656 |
| InChIKey | GQFITODJWOIYPF-UHFFFAOYSA-N |
| SMILES | BrCc1ccccc1I |
| Storage condition | Refrigerator |
Safety Information
| Symbol | GHS05, GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H314-H334 |
| Precautionary Statements | P261-P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | C:Corrosive;N:Dangerousfortheenvironment; |
| Risk Phrases | R22;R34;R43;R51/53 |
| Safety Phrases | S26-S36/37/39-S61-S45 |
| RIDADR | UN 3261 8/PG 2 |
| WGK Germany | 2 |
| Hazard Class | 8.0 |
| HS Code | 2903999090 |
Customs
| HS Code | 2903999090 |
|---|---|
| Summary | 2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Articles2
More Articles| Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound. J. Comb. Chem. 11(1) , 34-43, (2009) For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib... | |
| Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction. J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... |
Synonyms
| o-Iodobenzyl bromide |
| α-Bromo-2-iodotoluene |
| 2-Iodobenzyl bromide |
| 1-(Bromomethyl)-2-iodobenzene |
| IR B1E |
| MFCD00236046 |
| 1-(Bromomethyl)iodobenzene |
| Benzene, 1-(bromomethyl)-2-iodo- |
| 2-Iodo benzylbromide |
